Stay updated on Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial
Sign up to get notified when there's something new on the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page.

Latest updates to the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new page revision entry was added: Revision: v3.6.6, replacing the previous v3.6.5. This reflects a minor update to the page or site metadata without altering study content or user-facing features.SummaryDifference0.1%

- Check15 days agoChange DetectedA new entry, '2017 ( U.S. NIH Grant/Contract )', was added to the study's identifiers/funding section, recording NIH funding for the trial.SummaryDifference0.1%

- Check30 days agoChange DetectedThe page now displays a new revision label (v3.6.5) replacing the previous v3.6.4, indicating an update to the page's backend or content management system.SummaryDifference0.1%

- Check51 days agoChange DetectedThe revision tag on the page has been updated from v3.6.3 to v3.6.4. This indicates a minor version update rather than a substantive content change.SummaryDifference0.1%

- Check72 days agoChange DetectedPage revision tag updated from v3.6.0 to v3.6.3, indicating a backend update to the page version.SummaryDifference0.1%

- Check86 days agoChange DetectedA recruitment notice 'No longer looking for participants' was added and new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) were introduced. The Intervention/Treatment label was updated from 'Intervention / Treatment' and the revision tag updated to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Single-Dose Gene Therapy for Spinal Muscular Atrophy Type 1 Clinical Trial page.